Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance
- PMID: 8542959
Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance
Abstract
We have quantitated apoptotic cells by flow cytometry in human bone marrow (BM) and peripheral blood (PB) from normal donors and aplastic anemia (AA) patients, using the fluorescent DNA-binding dye 7-amino actinomycin D (7AAD). No significant difference was found in baseline percent apoptosis between normal and AA samples. Serum deprivation induced cell death to a greater degree in AA samples than in normal samples, but this was not significant. Using dual staining with anti CD34 antibody and 7AAD, we have shown that CD34+ progenitors in normal PB are significantly more apoptotic than those in normal BM. AA BM CD34+ cells contain a significantly greater proportion of apoptotic cells than normal BM CD34+ cells. Those AA patients with the lowest absolute number of CD34+ cells showed the highest proportion of apoptotic CD34+ cells. This appears to be related to clinical severity (transfusion dependence) at the time of study. We conclude that apoptosis is accelerated in AA BM progenitors and that this may contribute to the stem cell deficiency characteristic of this disorder.
Similar articles
-
Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.Am J Hematol. 1996 Aug;52(4):264-74. doi: 10.1002/(SICI)1096-8652(199608)52:4<264::AID-AJH5>3.0.CO;2-Q. Am J Hematol. 1996. PMID: 8701944
-
Induction of apoptosis in CD34+ cells by sera from patients with aplastic anemia.Hiroshima J Med Sci. 1999 Jun;48(2):57-63. Hiroshima J Med Sci. 1999. PMID: 10434475
-
The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.Bone Marrow Transplant. 1996 Feb;17(2):169-78. Bone Marrow Transplant. 1996. PMID: 8640162
-
CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity.Eur Ann Allergy Clin Immunol. 2008 Nov;40(3):90-103. Eur Ann Allergy Clin Immunol. 2008. PMID: 19334373 Review.
-
Hematopoietic stem cells in aplastic anemia.Arch Med Res. 2003 Nov-Dec;34(6):520-7. doi: 10.1016/j.arcmed.2003.09.009. Arch Med Res. 2003. PMID: 14734092 Review.
Cited by
-
Alterations in hematopoietic microenvironment in patients with aplastic anemia.Clin Transl Sci. 2009 Feb;2(1):67-74. doi: 10.1111/j.1752-8062.2008.00074.x. Clin Transl Sci. 2009. PMID: 20443870 Free PMC article.
-
iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors.Cell Death Dis. 2018 Jan 26;9(2):128. doi: 10.1038/s41419-017-0141-1. Cell Death Dis. 2018. PMID: 29374141 Free PMC article.
-
Current concepts in the pathophysiology and treatment of aplastic anemia.Blood. 2006 Oct 15;108(8):2509-19. doi: 10.1182/blood-2006-03-010777. Epub 2006 Jun 15. Blood. 2006. PMID: 16778145 Free PMC article. Review.
-
A new model of busulphan-induced chronic bone marrow aplasia in the female BALB/c mouse.Int J Exp Pathol. 2003 Feb;84(1):31-48. doi: 10.1046/j.1365-2613.2003.00239.x. Int J Exp Pathol. 2003. PMID: 12694485 Free PMC article.
-
Pathophysiology and treatment of aplastic anemia.Wien Klin Wochenschr. 2003 Aug 14;115(13-14):444-50. doi: 10.1007/BF03041027. Wien Klin Wochenschr. 2003. PMID: 13677262 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical